Mitochondrial membrane perturbations in cholestasis

Journal of Hepatology

Volumn 32, Issue 1, 2000, Pages 135-141

  Rodrigues, Cecília M P ^a,c   Steer, Clifford J ^b  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Ctro Patogenese Molec   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CASPASE; CYTOCHROME C OXIDASE; DNA FRAGMENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE C; URSODEOXYCHOLIC ACID;

APOPTOSIS; CHOLESTASIS; HUMAN; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033985520     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80200-7     Document Type: Article

References (84)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
2. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 68:1980;251-306.
3. Columbano A. Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem. 58:1995;181-190.
4. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell. 88:1997;347-354.
5. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
6. Evan G, Littlewood T. A matter of life and cell death. Science. 281:1998;1317-1322.
7. Patel T, Roberts LR, Jones BA, Gores GJ. Dysregulation of apoptosis as a mechanism of liver disease: an overview. Semin Liver Dis. 18:1998;105-114.
8. Kroemer G. Mitochondrial implication in apoptosis. Towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Diff. 4:1997;443-456.
9. Green DR, Reed JC. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
10. Wallace DC. Mitochondrial diseases in man and mouse. Science. 283:1999;1482-1488.
11. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326.
12. Suzuki A, Tsutomi Y, Yamamoto N, Shibutani T, Akahane K. Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death. Mol Cell Biol. 19:1999;3842-3847.
13. Scholmerich JM, Becher MS, Schmidt K, Schubert R, Kremer B, Feldhaus S, et al. Influence of hydroxylation and conjugation of bile acids on their membrane-damaging properties: studies on isolated hepatocytes and membrane vesicles. Hepatology. 4:1984;661-666.
14. Schumucker DL, Ohta M, Kanai S, Sato Y, Kitani K. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology. 12:1990;1216-1221.
15. Heuman DM, Mills AS, McCall J, Hylemon PB, Pandak WM, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology. 100:1991;203-211.
16. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology. 21:1995;1725-1741.
17. Rodrigues CMP, Fan G, Ma X, Kren BT, Steer CJ. A novel role of ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest. 101:1998;2790-2799.
18. Spivey JR, Bronk SF, Gores GJ. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. J Clin Invest. 92:1993;17-24.
19. Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest. 94:1994;2183-2192.
20. Jones BA, Rao Y-P, Stravitz RT, Gores GJ. Bile salt-induced apoptosis of hepatocytes involves activation of protein kinase C. Am J Physiol. 272:1997;G1109-G1115.
21. Rodrigues CMP, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med. 4:1998;165-178.
22. Stravitz RT, Rao Y-P, Vlahcevic ZR, Gurley EC, Jarvis WD, Hylemon PB. Hepatocellular protein kinase C activation by bile acids: implications for regulation of cholesterol 7α-hydroxylase. Am J Physiol. 271:1996;G293-G303.
23. Beuers U, Throckmorton DC, Anderson MS, Isales CM, Thasler W, Kullak-Ublick GA, et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology. 110:1996;1553-1563.
24. Kwo P, Patel T, Bronk SF, Gores GJ. Nuclear serine protease activity contributes to bile salt-induced apoptosis in hepatocytes. Am J Physiol. 268:1995;G613-G621.
25. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB (Fed Am Soc Exp Biol) J. 10:1996;587-597.
26. Roberts LR, Kurosawa H, Bronk SF, Fesmier PJ, Agellon AB, Leung W-Y, et al. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology. 113:1997;1714-1726.
27. Webster CRL, Anwer MS. Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology. 27:1998;1324-1331.
28. Patel T, Gores GJ. Inhibition of bile salt-induced hepatocyte apoptosis by the antioxidant lazaroid U83836E. Toxicol Appl Pharmacol. 142:1997;116-122.
29. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology. 25:1997;1077-1084.
30. Kurosawa H, Que FG, Roberts LR, Fesmier PJ, Gores GJ. Hepatocytes in bile duct-ligated rat express Bcl-2. Am J Physiol. 272:1997;G1587-G1593.
31. Kren BT, Trembley JH, Krajewski S, Behrens TW, Reed JC, Steer CJ. Modulation of apoptosis-associated genes bcl-2, bcl-x, and bax during rat liver regeneration. Cell Growth Differ. 7:1996;1633-1642.
32. Reed JC, Miyashita T, Takayama S, Wang H-G, Sato T, Krajewski S, et al. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem. 60:1996;23-32.
33. Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HLA, et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:1998;2027-2031.
34. Kane D, Sarafin T, Auton S, Hahn H, Gralla E, Valentine J, et al. Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species. Science. 262:1993;1274-1276.
35. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman C, Korsmeyer S. Bcl-2 functions in an antioxidant pathway in apoptosis. Cell. 75:1993;241-251.
36. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med. 3:1997;614-620.
37. Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
38. Zhang J, Reedy MC, Hannun YA, Obeid LM. Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits the initiation of formation of apoptotic bodies in chemotherapeutic agent-induced apoptosis. J Cell Biol. 145:1999;99-108.
39. Krebs JF, Armstrong RC, Srinivasan A, Aja T, Wong AM, Aboy A, et al. Activation of membrane-associated procaspase-3 is regulated by Bcl-2. J Cell Biol. 144:1999;915-926.
40. Que FG, Gores GJ, LaRusso NF. Development and initial application of an in vitro model of apoptosis in rodent cholangiocytes. Am J Physiol. 272:1997;G106-G115.
41. Kren BT, Rodrigues CMP, Setchell KDR, Steer CJ. Posttranscriptional regulation of mRNA levels in rat liver associated with deoxycholic acid feeding. Am J Physiol. 269:1995;G961-G973.
42. L prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. Mol Cell. 3:1999;159-167.
43. Newmeyer DD, Farschon DM, Reed JC. Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell. 79:1994;353-364.
44. Liu X, Kim CN, Yang R, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
45. L inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 57:1997;3115-3120.
46. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
47. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
48. Okuno S-i, Shimizu S, Ito T, Nomura M, Hamada E, Tsujimoto Y, et al. Bcl-2 prevents caspase-independent cell death. J Biol Chem. 273:1998;34272-34277.
49. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
50. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med. 182:1995;367-377.
51. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gómez-Monterrey I, Castedo M, et al. Mitochondrial control of nuclear apoptosis. J Exp Med. 183:1996;1533-1544.
52. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 184:1996;1155-1160.
53. Petit PX, Susin SA, Zamzami N, Mignotte B, Kroemer G. Mitochondria and programmed cell death: back to the future. FEBS Lett. 396:1996;7-13.
54. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today. 18:1997;44-51.
55. Susin AS, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, et al. Molecular characterization of mitochondrial apoptosis inducing factor. Nature. 397:1999;441-446.
56. Zamzami N, Marchetti P, Castedo M, Hirsch T, Susin SA, Masse B, et al. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384:1996;53-57.
57. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H, et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA. 95:1998;14681-14686.
58. L regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:1997;627-637.
59. Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO (Eur Mol Biol Organ) J. 17:1998;37-49.
60. 2+ ions. J Cell Biol. 143:1998;217-224.
61. Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA. 95:1998;4997-5002.
62. Krähenbühl S, Talos C, Fischer S, Reichen J. Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria. Hepatology. 19:1994;471-479.
63. Schaffner F, Bacchin PG, Hutterer F, Scharnbeck HH, Sarkozi LL, Denk H, et al. Mechanism of cholestasis. 4. Structural and biochemical changes in the liver and serum in rats after bile duct ligation. Gastroenterology. 60:1971;888-897.
64. Krähenbühl S, Stucki J, Reichen J. Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis. Hepatology. 15:1992;1161-1166.
65. Imberti R, Nieminen A-L, Herman B, Lemasters JJ. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporine A and trifluoperazine. J Pharmacol Exp Ther. 265:1993;392-400.
66. Pastorino JG, Synder JW, Serroni A, Hoek JB, Farber JL. Cyclosporine and carnitine prevent the anoxic cell death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J Biol Chem. 268:1993;13791-13798.
67. Botla R, Spivey JR, Aguilar H, Bronk SF, Gores GJ. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther. 272:1995;930-938.
68. Bernardi P. Modulation of the mitochondrial cyclosporine A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem. 267:1992;8834-8839.
69. Lieser MJ, Park J, Natori S, Jones BA, Bronk SF, Gores GJ. Cholestasis confers resistance to the rat liver mitochondrial permeability transition. Gastroenterology. 115:1998;693-701.
70. Sokol RJ, Devereaux M, Khandwala R. Effect of dietary lipid and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J Lipid Res. 32:1991;1349-1357.
71. Sokol RJ, Devereaux M, Khandwala R, O'Brien K. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. Hepatology. 17:1993;869-881.
72. Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology. 109:1995;1249-1256.
73. Rodrigues CMP, Ma X, Linehan-Stieers C, Fan G, Kren BT, Steer CJ. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Diff. 1999;. in press.
74. Hsu Y-T, Youle RJ. Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem. 272:1997;13829-13834.
75. Hsu Y-T, Youle RJ. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem. 273:1998;10777-10783.
76. Colombo C, Setchell KDR, Podda M, Crosignani A, Roda A, Curcio L, et al. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr. 117:1990;482-489.
77. Podda M, Ghezzi C, Battezzati PM, Crosignani A, Zuin M, Roda A. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology. 98:1990;1044-1050.
78. Beuers U, Spengler U, Kruis W, Aydemir Ü, Wiebecke B, Heldwein W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology. 16:1992;707-714.
79. Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez MC, Hernandez I, et al. Effect of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology. 15:1992;1043-1047.
80. Poupon RE, Poupon R, Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med. 330:1994;1342-1347.
81. Beuers U, Boyer JL, Paumgartner G. Ursodeoycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology. 28:1998;1449-1453.
82. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol. 114:1999;891-901.
83. L, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proc Natl Acad Sci USA. 96:1999;5492-5497.
84. Guicciardi ME, Gores GJ. Is ursodeoxycholic acid an antiapoptotic drug? Hepatology. 28:1998;1721-1723.